Effect of insulin and feed/fast cycle on vaccine efficacy and safety.

Informazioni relative al progetto

IMEIV

ID dell’accordo di sovvenzione: 101110724

DOI

10.3030/101110724

Progetto chiuso

Data della firma CE 7 Aprile 2023

Data di avvio 1 Ottobre 2023

Data di completamento 31 Marzo 2026

Finanziato da

• Marie Skłodowska-Curie Actions (MSCA)

Costo totale

Nessun dato

Contributo UE

€ 175 920,00

Coordinato da

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact of the project, including the dissemination and exploitation measures that are planned, and the target group(s) addressed. Regarding communication measures and public engagement strategy, the aim is to inform and reach out to society and show the activities performed, and the use and the benefits the project will have for citizens.

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cycle for all data sets that will be collected, processed or generated by the action. It is a document describing what data will be collected, processed or generated and following what methodology and standards, whether and how this data will be shared and/or made open, and how it will be curated and preserved

Pubblicazioni

Peer reviewed articles (4)

Peptide hormones and bile acids shaping immune tolerance of the liver: implications and applications

Autori: Gustav van Niekerk, Yana Kumpanenko, Joran Degryse, Johan Fevery, Kai Dallmeier
Pubblicato in: Protein & Cell, Numero 17, 2026, ISSN 1674-800X
Editore: Oxford University Press (OUP)
DOI: 10.1093/PROCEL/PWAF096

Cholecystokinin and gastrin as immune modulating hormones: Implications and applications

Autori: Gustav van Niekerk, Lara Kelchtermans, Elias Broeckhoven, Lotte Coelmont, Yeranddy A. Alpizar, Kai Dallmeier
Pubblicato in: Cytokine & Growth Factor Reviews, Numero 80, 2024, ISSN 1359-6101
Editore: Elsevier BV
DOI: 10.1016/J.CYTOGFR.2024.11.003

GLP-1R agonist therapy and vaccine response: Neglected implications

Autori: Gustav van Niekerk, Lotte Coelmont, Yeranddy A. Alpizar, Lara Kelchtermans, Elias Broeckhoven, Kai Dallmeier
Pubblicato in: Cytokine & Growth Factor Reviews, Numero 78, 2024, ISSN 1359-6101
Editore: Elsevier BV
DOI: 10.1016/J.CYTOGFR.2024.07.006

Beyond metabolic benefits: The underexplored immunomodulatory effects of GLP-1/glucagon agonists

Autori: Gustav van Niekerk, Johan Fevery, Kai Dallmeier
Pubblicato in: Journal of Hepatology, Numero 83, 2026, ISSN 0168-8278
Editore: Elsevier BV
DOI: 10.1016/J.JHEP.2025.02.025